Davis Jeffrey A.
Davis Jeffrey A.'s purchase track record
Davis Jeffrey A. has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 4/1/2024 | DLTR | $245K | -21.1% | -48.3% | +9.9% |
| 3/27/2023 | DLTR | $249K | +3.4% | -24.8% | +9.0% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Labcorp to Acquire OPKO Health's BioReference Assets for $722M. Labcorp has agreed to acquire select assets from OPKO Health's BioReference division for $722 million. This move expands Labcorp's capabilities in the diagnostics sector, a key area for the company's growth. The stock is currently trading near its 52-week high, reflecting investor interest in this strategic acquisition.
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Dollar Tree sees interest from high‑income shoppers amid uncertainty. Recent coverage notes that even higher‑income consumers are turning to Dollar Tree for lower‑cost alternatives as economic conditions remain uncertain. The shift suggests broader appeal for the retailer's value offering and may influence sales dynamics. The stock is currently trading with an RSI near 64 and close to a support level around $111.98.
Transaction History
| FDXF | ▲ Buy | Grant | 1,169 | $0 | 6/29/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 897 | — | 2/11/2026 | View on chart |
| LH | ▲ Buy | Option Exercise | 944 | — | 2/6/2025 | View on chart |
| DLTR | ▼ Sell | Tax Withholding | 2,750 | $192K | 11/25/2024 | View on chart |
| DLTR | ▲ Buy | Open Market | 1,800 | $245K | 4/1/2024 | View on chart |
| DLTR | ▲ Buy | Grant | 5,518 | $0 | 4/1/2024 | View on chart |
| DLTR | ▼ Sell | Tax Withholding | 472 | $63K | 3/31/2024 | View on chart |
| LH | ▲ Buy | Option Exercise | 947 | — | 2/7/2024 | View on chart |
| DLTR | ▼ Sell | Tax Withholding | 1,326 | $156K | 11/25/2023 | View on chart |
| DLTR | ▲ Buy | Grant | 4,702 | $0 | 3/31/2023 | View on chart |
| DLTR | ▲ Buy | Open Market | 1,790 | $249K | 3/27/2023 | View on chart |
| LH | ▲ Buy | Option Exercise | 742 | — | 2/11/2023 | View on chart |
| DLTR | ▲ Buy | Grant | 13,216 | $2.0M | 11/25/2022 | View on chart |
| LH | ▲ Buy | Option Exercise | 771 | — | 2/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
FDXF Earnings Preview Highlights Upcoming Quarterly Report
FedEx Freight is preparing to release its quarterly earnings, with recent previews outlining what investors should expect from the report. This upcoming event is key for assessing the company's current performance. The stock is currently trading near its 52-week low, which adds context to the market's anticipation of these results.
FDXF Earnings Preview Highlights Upcoming Quarterly Report. FedEx Freight is preparing to release its quarterly earnings, with recent previews outlining what investors should expect from the report. This upcoming event is key for assessing the company's current performance. The stock is currently trading near its 52-week low, which adds context to the market's anticipation of these results.